• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬“尿素诱导性肾病”的筛检研究

Sieving studies in 'urea-induced nephropathy' in the dog.

作者信息

Vanrenterghem Y, Vanholder R, Lammens-Verslijpe M, Lambert P P

出版信息

Clin Sci (Lond). 1980 Jan;58(1):65-75. doi: 10.1042/cs0580065.

DOI:10.1042/cs0580065
PMID:7353355
Abstract
  1. The intrarenal infusion of concentrated urea after clamping of the renal artery produced immediate proteinuria in the dog. The predominant lesion on ultramicroscopy was destruction of the epithelial layer. Colloidal iron staining showed decreased fixed anionic charges in the capillary wall. 2. Sieving studies with neutral macromolecules such as 125I-labelled polyvinylpyrrolidone and [3H]dextran or an electronegatively charged polymer, [3H]dextran sulphate, showed a moderate increase in permeablility to the neutral tracers and a much more severe alteration of the lectrostatic barrier to the anionic polymer. The fractional clearance of dextran sulphate molecules increased to a greater extent than clearance of neutral dextrans of comparable size. 3. The shape of the curve relating the fractional clearance of dextran sulphate to molecular size is also modified in the contralateral kidney. This may be due to elevated plasma angiotensin II concentrations.
摘要
  1. 肾动脉夹闭后向肾内输注浓缩尿素可使犬立即出现蛋白尿。超微镜下的主要病变是上皮层破坏。胶体铁染色显示毛细血管壁中固定阴离子电荷减少。2. 用中性大分子如125I标记的聚乙烯吡咯烷酮和[3H]葡聚糖或带负电荷的聚合物[3H]硫酸葡聚糖进行筛分研究,结果显示对中性示踪剂的通透性有中度增加,而对阴离子聚合物的静电屏障改变更为严重。硫酸葡聚糖分子的分数清除率比大小相当的中性葡聚糖的清除率增加幅度更大。3. 对侧肾脏中硫酸葡聚糖分数清除率与分子大小关系曲线的形状也发生了改变。这可能是由于血浆血管紧张素II浓度升高所致。

相似文献

1
Sieving studies in 'urea-induced nephropathy' in the dog.犬“尿素诱导性肾病”的筛检研究
Clin Sci (Lond). 1980 Jan;58(1):65-75. doi: 10.1042/cs0580065.
2
Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy.肾小球肾炎和糖尿病肾病中分数葡聚糖和蛋白质清除率
Clin Sci (Lond). 1987 Mar;72(3):289-96. doi: 10.1042/cs0720289.
3
Measurement of glomerular permeability to polydisperse radioactively-labelled macromolecules in normal rabbits.正常家兔肾小球对多分散放射性标记大分子通透性的测量。
Clin Sci. 1968 Jun;34(3):505-14.
4
Human glomerular permeability to macromolecules in health and disease.健康与疾病状态下人体肾小球对大分子物质的通透性
Clin Sci. 1968 Jun;34(3):515-29.
5
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate.肾小球毛细血管壁的通透选择性。使用硫酸葡聚糖对大鼠实验性肾小球肾炎的研究。
J Clin Invest. 1976 May;57(5):1287-94. doi: 10.1172/JCI108396.
6
Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran.肾小球毛细血管壁对大分子物质的选择通透性。II. 使用中性葡聚糖对大鼠进行的实验研究。
Biophys J. 1975 Sep;15(9):887-906. doi: 10.1016/S0006-3495(75)85863-2.
7
The morphological basis of the glomerular permeability to proteins.肾小球对蛋白质通透性的形态学基础。
Ric Clin Lab. 1977 Oct-Dec;7(4):312-27. doi: 10.1007/BF02886645.
8
Transglomerular cationic macromolecular flux is mediated by a convection-binding mechanism.经肾小球阳离子大分子通量由对流结合机制介导。
Am J Physiol. 1989 May;256(5 Pt 2):F882-93. doi: 10.1152/ajprenal.1989.256.5.F882.
9
Glomerular and postglomerular permselectivity to anionic dextrans in the dog.犬肾小球和肾小球后对阴离子葡聚糖的选择通透性
Am J Physiol. 1984 Dec;247(6 Pt 2):F965-74. doi: 10.1152/ajprenal.1984.247.6.F965.
10
Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.糖尿病肾病中蛋白尿与肾小球屏障的功能特性
Kidney Int. 1980 May;17(5):669-76. doi: 10.1038/ki.1980.78.

引用本文的文献

1
Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.健康人和肾病患者肾小球滤过屏障的电荷选择性
J Clin Invest. 1993 Nov;92(5):2274-82. doi: 10.1172/JCI116831.
2
Mechanisms of proteinuria in nephrotic humans.肾病患者蛋白尿的机制。
Pediatr Nephrol. 1994 Feb;8(1):107-12. doi: 10.1007/BF00868285.